Please login or register first to view this content.
Gastrohepatic Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Taxing Sweetened Beverages Reduces Volume Sold
Low-Calorie Sweetened Drinks Do Not Cut Calories in Children
Cyramza Approved to Treat Hepatocellular Carcinoma
Coagulopathy Linked to Antidiarrheal Med Ingestion in Patient With Underlying Liver Disease
BLA for Subcutaneous Formulation of Vedolizumab Submitted for FDA Review
FDA Passes on Barhemsys NDA Again Due to Facility Issues
Glycopyrrolate Injection Now Available in Ready-to-Administer Prefilled Syringes
Elafibranor Gets Breakthrough Therapy Designation for Primary Biliary Cholangitis
Not so Inactive: Excipients in Medications May Trigger Adverse Reactions in Some Patients
Yosprala Available Again for Secondary Prevention of CVD With Gastroprotection
Older Patients With Crohn Disease May Benefit From Early Combo Tx
Clindamycin-Induced Acute Kidney Injury Following Treatment for Chronic Osteomyelitis
FDA Rejects NDA for Gastroparesis Treatment Gimoti
IBS-C Treatment Zelnorm Returning to US Market
Does PPI Use Increase the Risk of Gynecomastia?
Avycaz Approved for Pediatric Use to Treat Complicated Intra-Abdominal, Urinary Tract Infections
Ustekinumab Effective as Maintenance Therapy in Moderate to Severe Ulcerative Colitis
Vedolizumab Tops Adalimumab in Head-to-Head Ulcerative Colitis Trial
